Bayesian Meta-Experimental Design: Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
From MaRDI portal
Publication:2912356
DOI10.1111/j.1541-0420.2011.01679.xzbMath1274.62795WikidataQ41867314 ScholiaQ41867314MaRDI QIDQ2912356
No author found.
Publication date: 14 September 2012
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3571108
62P10: Applications of statistics to biology and medical sciences; meta analysis
Related Items
Bayesian hierarchical random-effects meta-analysis and design of phase I clinical trials, Normalized power prior Bayesian analysis, Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome
Cites Work
- Bayesian Design of Noninferiority Trials for Medical Devices Using Historical Data
- Bayesianly justifiable and relevant frequency calculations for the applied statistician
- A simulation-based approach to Bayesian sample size determination for performance under a given model and for separating models
- Bayesian sample size determination for binomial proportions
- Sampling and Bayes' Inference in Scientific Modelling and Robustness
- Bayesian survival analysis